sales@fnfresearch.comTel: +91 96043 17127 | USA: 1 (347) 690-0211

Search Market Research Report

Home / Category / Healthcare / Europe Precision Medicine

Europe Precision Medicine Market By Technology (Big Data Analytics, Gene Sequencing, Companion Diagnostics, Bioinformatics, Drug Discovery, and Others), By End-User(Diagnostic Tool Companies, Clinical Labs, Healthcare IT/Big Data Companies, and Pharma & Biotech Companies), and By Application (Oncology, Respiratory, CNS, Immunology, and Others): Industry Perspective, Comprehensive Analysis, and Forecast, 2018 – 2025

  • Publish On: Dec-2019
  • Total Pages: 180
  • Report Code: FAF-275
  • Base Year: 2018
  • Format:

Industry Insights

The report covers the forecast and analysis of the Europe Precision Medicine market. The study provides historical data from 2015 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the Europe Precision Medicine market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Europe Precision Medicine market.

In order to give the users of this report a comprehensive view of the Europe Precision Medicine market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product & service launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the Europe Precision Medicine market by segmenting the market based on technology, end-user, application, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025.

Patient outcomes are likely to be improved through the utility of precision drugs in the European continent. It comprises of medical institutes ready to make genetic testing & analytics tools and investors willing to compensate the drug costs. Apart from this, drug institutes in Europe are focusing on creating new personalized modes of treatments while companion diagnostics providers are concentrating on gathering data efficiently. Additionally, genetic analytics help in interpreting the outcomes of the clinical data of the patients.

The Europe precision medicine industry is sectored based on technology, end-user, and application. Based on the technology, the industry is segregated into Big Data Analytics, Gene Sequencing, Companion Diagnostics, Bioinformatics, Drug Discovery, and Others, In terms of end-user, the precision medicine market in Europe is classified into Diagnostic Tool Companies, Clinical Labs, Healthcare IT/Big Data Companies, and Pharma & Biotech Companies. Application-wise the market is divided into Oncology, Respiratory, CNS, Immunology, and Others.


Top Players in the Market Are:



Some of the key players involved in the business include Thermo Fisher Scientific, Cepheid, Intel Corporation, Randox Laboratories, Novartis, Almac Group, Illumina, Johnson & Johnson, Qiagen, GE Healthcare, Roche, IBM, Laboratory Corporation of America Holdings, Abbott Laboratories, Biomrieux Sa, and Healthcore among others.


Global Europe Precision Medicine : Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Key Features of Europe Precision Medicine Report:

  • Europe Precision Medicine structure: Overview, industry life cycle analysis, supply chain analysis
  • Europe Precision Medicine : Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
  • Europe Precision Medicine size, trend, and forecast analysis
  • Europe Precision Medicine segments’ trend and forecast
  • Europe Precision Medicine ’s competitive landscapes: Market share, Product portfolio, New product launches, etc.
  • Europe Precision Medicine attractiveness and associated growth opportunities
  • Emerging trends in the Europe Precision Medicine .
  • Strategic growth opportunities for the existing and new players
  • Key success factors

Benefits of Buying from Facts & Factors:

  • Our proven methodologies and systematic analysis help in making confident business and strategic decisions.
  • A market study that conducts at Facts & Factors Market Research can save significant cost and time, and can help prevent making costly mistakes.

Table of Content

  1. CHAPTER 1. Executive Summary 19
  2. CHAPTER 2. Europe Precision Medicine market – Technology Analysis 22
    1. 2.1. Europe Precision Medicine Market – Technology Overview 22
    2. 2.2. Europe Precision Medicine Market Share, by Technology, 2018 & 2025 (USD Million) 22
    3. 2.3. Big Data Analytics 24
      1. 2.3.1. Big Data Analytics Europe Precision Medicine Market, 2015-2025 (USD Million) 24
    4. 2.4. Gene Sequencing 25
      1. 2.4.1. Gene Sequencing Europe Precision Medicine Market, 2015-2025 (USD Million) 25
    5. 2.5. Companion Diagnostics 26
      1. 2.5.1. Companion Diagnostics Europe Precision Medicine Market, 2015-2025 (USD Million) 26
    6. 2.6. Bioinformatics 27
      1. 2.6.1. Bioinformatics Europe Precision Medicine Market, 2015-2025 (USD Million) 27
    7. 2.7. Drug Discovery 28
      1. 2.7.1. Drug Discovery Europe Precision Medicine Market, 2015-2025 (USD Million) 28
    8. 2.8. Others 29
      1. 2.8.1. Others Europe Precision Medicine Market, 2015-2025 (USD Million) 29
  3. CHAPTER 3. Europe Precision Medicine market – End-User Analysis 29
    1. 3.1. Europe Precision Medicine Market – End-User Overview 29
    2. 3.2. Europe Precision Medicine Market Share, by End-User, 2018 & 2025 (USD Million) 30
    3. 3.3. Diagnostic Tool Companies 31
      1. 3.3.1. Diagnostic Tool Companies Europe Precision Medicine Market, 2015-2025 (USD Million) 31
    4. 3.4. Clinical Labs 32
      1. 3.4.1. Clinical Labs Europe Precision Medicine Market, 2015-2025 (USD Million) 32
    5. 3.5. Healthcare IT/Big Data Companies 33
      1. 3.5.1. Healthcare IT/Big Data Companies Europe Precision Medicine Market, 2015-2025 (USD Million) 33
    6. 3.6. Pharma & Biotech Companies 34
      1. 3.6.1. Pharma & Biotech Companies Europe Precision Medicine Market, 2015-2025 (USD Million) 34
  4. CHAPTER 4. Europe Precision Medicine market – Application Analysis 34
    1. 4.1. Europe Precision Medicine Market – Application Overview 34
    2. 4.2. Europe Precision Medicine Market Share, by Application, 2018 & 2025 (USD Million) 35
    3. 4.3. Oncology 36
      1. 4.3.1. Oncology Europe Precision Medicine Market, 2015-2025 (USD Million) 36
    4. 4.4. Respiratory 37
      1. 4.4.1. Respiratory Europe Precision Medicine Market, 2015-2025 (USD Million) 37
    5. 4.5. CNS 38
      1. 4.5.1. CNS Europe Precision Medicine Market, 2015-2025 (USD Million) 38
    6. 4.6. Immunology 39
      1. 4.6.1. Immunology Europe Precision Medicine Market, 2015-2025 (USD Million) 39
    7. 4.7. Others 40
      1. 4.7.1. Others Europe Precision Medicine Market, 2015-2025 (USD Million) 40
  5. CHAPTER 5. Europe Precision Medicine market – Regional Analysis 41
    1. 5.1. Europe Precision Medicine Market Regional Overview 41
    2. 5.2. Europe Precision Medicine Market Share, by Region, 2018 & 2025 (Value) 41
    3. 5.3. Europe 42
      1. 5.3.1. Europe Precision Medicine Market size and forecast, 2015-2025 42
      2. 5.3.2. Europe Precision Medicine Market, by Country, 2018 & 2025 (USD Million) 42
      3. 5.3.3. Europe Precision Medicine Market, by Technology, 2015-2025 44
        1. 5.3.3.1. Europe Precision Medicine Market, by Technology, 2015-2025 (USD Million) 44
      4. 5.3.4. Europe Precision Medicine Market, by End-User, 2015-2025 45
        1. 5.3.4.1. Europe Precision Medicine Market, by End-User, 2015-2025 (USD Million) 45
      5. 5.3.5. Europe Precision Medicine Market, by Application, 2015-2025 46
        1. 5.3.5.1. Europe Precision Medicine Market, by Application, 2015-2025 (USD Million) 46
      6. 5.3.6. Germany 47
        1. 5.3.6.1. Germany Market size and forecast, 2015-2025 (USD Million) 47
      7. 5.3.7. France 48
        1. 5.3.7.1. France Market size and forecast, 2015-2025 (USD Million) 48
      8. 5.3.8. U.K. 49
        1. 5.3.8.1. U.K. Market size and forecast, 2015-2025 (USD Million) 49
      9. 5.3.9. Italy 50
        1. 5.3.9.1. Italy Market size and forecast, 2015-2025 (USD Million) 50
      10. 5.3.10. Spain 51
        1. 5.3.10.1. Spain Market size and forecast, 2015-2025 (USD Million) 51
      11. 5.3.11. Nordic Countries 52
        1. 5.3.11.1. Nordic Countries Market size and forecast, 2015-2025 (USD Million) 52
      12. 5.3.12. Benelux Union 53
        1. 5.3.12.1. Benelux Union Market size and forecast, 2015-2025 (USD Million) 53
      13. 5.3.13. Rest of Europe 54
        1. 5.3.13.1. Rest of Europe Market size and forecast, 2015-2025 (USD Million) 54
  6. CHAPTER 6. Europe Precision Medicine market – Competitive Landscape 55
    1. 6.1. Competitor Market Share – Revenue 55
    2. 6.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players 57
    3. 6.3. Strategic Development 58
      1. 6.3.1. Acquisitions and Mergers 58
      2. 6.3.2. New Products 58
      3. 6.3.3. Research & Development Activities 58
  7. CHAPTER 7. Company Profiles 59
    1. 7.1. Thermo Fisher Scientific 59
      1. 7.1.1. Company Overview 59
      2. 7.1.2. Thermo Fisher Scientific Revenue and Gross Margin 59
      3. 7.1.3. Product portfolio 60
      4. 7.1.4. Recent initiatives 61
    2. 7.2. Cepheid 61
      1. 7.2.1. Company Overview 61
      2. 7.2.2. Cepheid Revenue and Gross Margin 61
      3. 7.2.3. Product portfolio 62
      4. 7.2.4. Recent initiatives 63
    3. 7.3. Intel Corporation 63
      1. 7.3.1. Company Overview 63
      2. 7.3.2. Intel Corporation Revenue and Gross Margin 63
      3. 7.3.3. Product portfolio 64
      4. 7.3.4. Recent initiatives 65
    4. 7.4. Randox Laboratories 65
      1. 7.4.1. Company Overview 65
      2. 7.4.2. Randox Laboratories Revenue and Gross Margin 65
      3. 7.4.3. Product portfolio 66
      4. 7.4.4. Recent initiatives 67
    5. 7.5. Novartis 67
      1. 7.5.1. Company Overview 67
      2. 7.5.2. Novartis Revenue and Gross Margin 67
      3. 7.5.3. Product portfolio 68
      4. 7.5.4. Recent initiatives 69
    6. 7.6. Almac Group 69
      1. 7.6.1. Company Overview 69
      2. 7.6.2. Almac Group Revenue and Gross Margin 69
      3. 7.6.3. Product portfolio 70
      4. 7.6.4. Recent initiatives 71
    7. 7.7. Illumina 71
      1. 7.7.1. Company Overview 71
      2. 7.7.2. Illumina Revenue and Gross Margin 71
      3. 7.7.3. Product portfolio 72
      4. 7.7.4. Recent initiatives 73
    8. 7.8. Johnson & Johnson 73
      1. 7.8.1. Company Overview 73
      2. 7.8.2. Johnson & Johnson Revenue and Gross Margin 73
      3. 7.8.3. Product portfolio 74
      4. 7.8.4. Recent initiatives 75
    9. 7.9. Qiagen 75
      1. 7.9.1. Company Overview 75
      2. 7.9.2. Qiagen Revenue and Gross Margin 75
      3. 7.9.3. Product portfolio 76
      4. 7.9.4. Recent initiatives 77
    10. 7.10. GE Healthcare 77
      1. 7.10.1. Company Overview 77
      2. 7.10.2. GE Healthcare Revenue and Gross Margin 77
      3. 7.10.3. Product portfolio 78
      4. 7.10.4. Recent initiatives 79
    11. 7.11. Roche 79
      1. 7.11.1. Company Overview 79
      2. 7.11.2. Roche Revenue and Gross Margin 79
      3. 7.11.3. Product portfolio 80
      4. 7.11.4. Recent initiatives 81
    12. 7.12. IBM 81
      1. 7.12.1. Company Overview 81
      2. 7.12.2. IBM Revenue and Gross Margin 81
      3. 7.12.3. Product portfolio 82
      4. 7.12.4. Recent initiatives 83
    13. 7.13. Laboratory Corporation of America Holdings 83
      1. 7.13.1. Company Overview 83
      2. 7.13.2. Laboratory Corporation of America Holdings Revenue and Gross Margin 83
      3. 7.13.3. Product portfolio 84
      4. 7.13.4. Recent initiatives 85
    14. 7.14. Abbott Laboratories 85
      1. 7.14.1. Company Overview 85
      2. 7.14.2. Abbott Laboratories Revenue and Gross Margin 85
      3. 7.14.3. Product portfolio 86
      4. 7.14.4. Recent initiatives 87
    15. 7.15. Biomrieux Sa 87
      1. 7.15.1. Company Overview 87
      2. 7.15.2. Biomrieux Sa Revenue and Gross Margin 87
      3. 7.15.3. Product portfolio 88
      4. 7.15.4. Recent initiatives 89
    16. 7.16. Healthcore 89
      1. 7.16.1. Company Overview 89
      2. 7.16.2. Healthcore Revenue and Gross Margin 89
      3. 7.16.3. Product portfolio 90
      4. 7.16.4. Recent initiatives 91
  8. CHAPTER 8. Europe Precision Medicine — Industry Analysis 92
    1. 8.1. Europe Precision Medicine Market – Key Trends 92
      1. 8.1.1. Market Drivers 93
      2. 8.1.2. Market Restraints 93
      3. 8.1.3. Market Opportunities 94
    2. 8.2. Value Chain Analysis 95
    3. 8.3. Technology Roadmap and Timeline 96
    4. 8.4. Europe Precision Medicine Market – Attractiveness Analysis 97
      1. 8.4.1. By Technology 97
      2. 8.4.2. By End-User 97
      3. 8.4.3. By Application 98
      4. 8.4.4. By Region 100
  9. CHAPTER 9. Marketing Strategy Analysis, Distributors 101
    1. 9.1. Marketing Channel 101
    2. 9.2. Direct Marketing 102
    3. 9.3. Indirect Marketing 102
    4. 9.4. Marketing Channel Development Trend 102
    5. 9.5. Economic/Political Environmental Change 103
  10. CHAPTER 10. Report Conclusion 104
  11. CHAPTER 11. Research Approach & Methodology 105
    1. 11.1. Report Description 105
    2. 11.2. Research Scope 106
    3. 11.3. Research Methodology 106
      1. 11.3.1. Secondary Research 107
      2. 11.3.2. Primary Research 108
      3. 11.3.3. Models 109
        1. 11.3.3.1. Company Share Analysis Model 109
        2. 11.3.3.2. Revenue Based Modeling 110
        3. 11.3.3.3. Research Limitations 110

        List of Figures

        FIG. 1  Europe Precision Medicine Market, 2015-2025 (USD Million) 22
        FIG. 2  Europe Precision Medicine Market Share, by Technology, 2018 & 2025 (USD Million) 23
        FIG. 3  Big Data Analytics Europe Precision Medicine Market, 2015-2025 (USD Million) 25
        FIG. 4  Gene Sequencing Europe Precision Medicine Market, 2015-2025 (USD Million) 26
        FIG. 5  Companion Diagnostics Europe Precision Medicine Market, 2015-2025 (USD Million) 27
        FIG. 6  Bioinformatics Europe Precision Medicine Market, 2015-2025 (USD Million) 28
        FIG. 7  Drug Discovery Europe Precision Medicine Market, 2015-2025 (USD Million) 29
        FIG. 8  Others Europe Precision Medicine Market, 2015-2025 (USD Million) 30
        FIG. 9  Europe Precision Medicine Market Share, by End-User, 2018 & 2025 (USD Million) 31
        FIG. 10  Diagnostic Tool Companies Europe Precision Medicine Market, 2015-2025 (USD Million) 32
        FIG. 11  Clinical Labs Europe Precision Medicine Market, 2015-2025 (USD Million) 33
        FIG. 12  Healthcare IT/Big Data Companies Europe Precision Medicine Market, 2015-2025 (USD Million) 34
        FIG. 13  Pharma & Biotech Companies Europe Precision Medicine Market, 2015-2025 (USD Million) 35
        FIG. 14  Europe Precision Medicine Market Share, by Application, 2018 & 2025 (USD Million) 36
        FIG. 15  Oncology Europe Precision Medicine Market, 2015-2025 (USD Million) 37
        FIG. 16  Respiratory Europe Precision Medicine Market, 2015-2025 (USD Million) 38
        FIG. 17  CNS Europe Precision Medicine Market, 2015-2025 (USD Million) 39
        FIG. 18  Immunology Europe Precision Medicine Market, 2015-2025 (USD Million) 40
        FIG. 19  Others Europe Precision Medicine Market, 2015-2025 (USD Million) 41
        FIG. 20  Europe Precision Medicine Market Share, by Region, 2018 & 2025 42
        FIG. 21 Europe Precision Medicine Market, 2015-2025 43
        FIG. 22 Germany Europe Precision Medicine Market, 2015-2025 48
        FIG. 23 France Europe Precision Medicine Market, 2015-2025 49
        FIG. 24 U.K. Europe Precision Medicine Market, 2015-2025 50
        FIG. 25 Italy Europe Precision Medicine Market, 2015-2025 51
        FIG. 26 Spain Europe Precision Medicine Market, 2015-2025 52
        FIG. 27 Nordic Countries Europe Precision Medicine Market, 2015-2025 53
        FIG. 28 Benelux Union Europe Precision Medicine Market, 2015-2025 54
        FIG. 29 Rest of Europe Precision Medicine Market, 2015-2025 55
        FIG. 30 Competitor Market Share – Revenue 56
        FIG. 31 Thermo Fisher Scientific Revenue and Growth Rate 61
        FIG. 32 Thermo Fisher Scientific Market Share 61
        FIG. 33 Cepheid Revenue and Growth Rate 63
        FIG. 34 Cepheid Market Share 63
        FIG. 35 Intel Corporation Revenue and Growth Rate 65
        FIG. 36 Intel Corporation Market Share 65
        FIG. 37 Randox Laboratories Revenue and Growth Rate 67
        FIG. 38 Randox Laboratories Market Share 67
        FIG. 39 Novartis Revenue and Growth Rate 69
        FIG. 40 Novartis Market Share 69
        FIG. 41 Almac Group Revenue and Growth Rate 71
        FIG. 42 Almac Group Market Share 71
        FIG. 43 Illumina Revenue and Growth Rate 73
        FIG. 44 Illumina Market Share 73
        FIG. 45 Johnson & Johnson Revenue and Growth Rate 75
        FIG. 46 Johnson & Johnson Market Share 75
        FIG. 47 Qiagen Revenue and Growth Rate 77
        FIG. 48 Qiagen Market Share 77
        FIG. 49 GE Healthcare Revenue and Growth Rate 79
        FIG. 50 GE Healthcare Market Share 79
        FIG. 51 Roche Revenue and Growth Rate 81
        FIG. 52 Roche Market Share 81
        FIG. 53 IBM Revenue and Growth Rate 83
        FIG. 54 IBM Market Share 83
        FIG. 55 Laboratory Corporation of America Holdings Revenue and Growth Rate 85
        FIG. 56 Laboratory Corporation of America Holdings Market Share 85
        FIG. 57 Abbott Laboratories Revenue and Growth Rate 87
        FIG. 58 Abbott Laboratories Market Share 87
        FIG. 59 Biomrieux Sa Revenue and Growth Rate 89
        FIG. 60 Biomrieux Sa Market Share 89
        FIG. 61 Healthcore Revenue and Growth Rate 91
        FIG. 62 Healthcore Market Share 91
        FIG. 63 Market Dynamics 93
        FIG. 64  Europe Precision Medicine – Value Chain Analysis 96
        FIG. 65 Technology Roadmap and Timeline 97
        FIG. 66 Market Attractiveness Analysis – By Technology 98
        FIG. 67 Market Attractiveness Analysis – By End-User 99
        FIG. 68 Market Attractiveness Analysis – By Application 99
        FIG. 69 Market Attractiveness Analysis – By Region 101
        FIG. 70 Market Channel 102
        FIG. 71 Marketing Channel Development Trend 103
        FIG. 72 Growth in World Gross Product, 2008-2018 104
        
        

        List of Tables

        TABLE 1  Europe Precision Medicine Market, 2018 & 2025 (USD Million) 20
        TABLE 2  Europe Precision Medicine market, by Technology, 2015-2025 (USD Million) 22
        TABLE 3  Europe Precision Medicine market, by End-User, 2015-2025 (USD Million) 30
        TABLE 4  Europe Precision Medicine market, by Application, 2015-2025 (USD Million) 35
        TABLE 5  Europe Precision Medicine market, by Region, 2015-2025 (USD Million) 41
        TABLE 6 Europe Precision Medicine Market, by Technology, 2015-2025 (USD Million) 44
        TABLE 7 Europe Precision Medicine Market, by End-User, 2015-2025 (USD Million) 45
        TABLE 8 Europe Precision Medicine Market, by Application, 2015-2025 (USD Million) 46
        TABLE 9  Europe Precision Medicine Market - Company Revenue Analysis 2015-2018 (USD Million) 55
        TABLE 10  Europe Precision Medicine Market - Company Revenue Share Analysis 2015-2018(%) 57
        TABLE 11 Acquisitions and Mergers 58
        TABLE 12 New Product/Service Launch 58
        TABLE 13 Research & Development Activities 58
        TABLE 14 Market Drivers 93
        TABLE 15 Market Restraints 93
        TABLE 16 Market Opportunities 94
        
        

Industry Major Market Players

  •  Thermo Fisher Scientific,
  •  Cepheid,
  •  Intel Corporation,
  •  Rox Laboratories,
  •  Novartis,
  •  Almac Group,
  •  Illumina,
  •  Johnson & Johnson,
  •  Qiagen,
  •  GE Healthcare,
  •  Roche,
  •  IBM,
  •  Laboratory Corporation of America Holdings,
  •  Abbott Laboratories,
  •  Biomrieux SA,
  •  Healthcore among others.

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2020 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions